Stock Ratings | Wells Fargo raised its price target for SanDisk (SNDK) to $1,620; B. Riley initiated coverage of Lyell Immunopharma (LYEL) with a buy rating and a price target of $44, representing a potential upside of 242.68%.
IREN Limited IREN | 0.00 | |
FTAI Aviation Ltd. FTAI | 0.00 | |
HUT 8 HUT | 0.00 | |
Lyell Immunopharma, Inc. LYEL | 0.00 | |
Strive ASST | 0.00 |
The ratings of major US investment banks are used to track the latest valuations and target prices on Wall Street daily, and to explore potential equity investment opportunities.
Risk warning:
Investing in small-cap stocks can be risky. Be prepared for potential challenges related to liquidity, high volatility, limited information, and financial instability. Always diversify your investments.
Today's key assessments and concerns
HC Wainwright & Co.: Maintaining a "buy" rating on IREN ( IREN Limited(IREN.US) ) stock, while raising the price target from $85 to $90.
BTIG: Maintaining a "buy" rating on FTAI Aviation ( FTAI Aviation Ltd.(FTAI.US) ), while raising the price target from $340 to $400.
Benchmark: Maintaining a "buy" rating for Hut 8 ( HUT 8(HUT.US) ), with a price target raised from $165 to $195.
B. Riley Securities: Initial rating for Lyell Immunopharma ( Lyell Immunopharma, Inc.(LYEL.US) ) at "Buy", with a target price of $44.
TD Securities: Maintaining a "buy" rating on Strive ( Strive(ASST.US) ), while lowering the price target from $32 to $28.
| The symbol | Classification | Target price | Current price | Percentage of potential increase/decrease | (Classification) Agency |
| IREN Limited(IREN.US) | to lift | $90.0 | $41.28 | 118.02% | HC Wainwright & Co. |
| FTAI Aviation Ltd.(FTAI.US) | to lift | $400.0 | $222.49 | 79.78% | BTIG |
| HUT 8(HUT.US) | to lift | $195.0 | $109.86 | 77.5% | Benchmark |
| Everforth, Inc.(EFOR.US) | to lift | $36.0 | $20.38 | 76.64% | Truist Securities |
| Fluence Energy, Inc. Class A(FLNC.US) | to lift | $24.0 | $14.66 | 63.71% | Citigroup |
| Lyell Immunopharma, Inc.(LYEL.US) | Initial classification | $44.0 | $12.84 | 242.68% | B. Riley Securities |
| Strive(ASST.US) | cut | $28.0 | $12.67 | 120.99% | TD Securites |
| Upstart(UPST.US) | cut | $61.0 | $28.64 | 112.99% | Citigroup |
| USA Rare Earth(USAR.US) | cut | $33.0 | $15.82 | 108.6% | Needham |
| Applied Optoelectronics, Inc.(AAOI.US) | cut | $220.0 | $110.52 | 99.06% | Needham |
comments:
Target price unit and current price: US Dollar;
Current price: As of the latest closing price of US stocks;
Potential percentage increase/potential decrease = (Agency target price - current price) / current price 100% (Current price = Last closing price up to the time of the count)
Lifting
Argus Research: Maintaining a "buy" rating on CrowdStrike Holdings CrowdStrike(CRWD.US) ), raising its price target from $200 to $230.
Truist Securities: Upgraded CoreWeave ( CoreWeave(CRWV.US) ) rating to "buy", while lowering the price target from $131 to $126.
Guggenheim: Maintaining a "buy" rating on Datadog ( Datadog(DDOG.US) ) stock, while raising the price target from $225 to $300.
Keybanc: Maintaining an "overweight" rating on Robinhood Markets ( Robinhood(HOOD.US) ), while raising the price target from $100 to $125.
Wells Fargo: Maintaining a "Market-Similar Weight" rating for SanDisk ( Sandisk Corporation(SNDK.US) ), while raising its price target from $1,250 to $1,620.
First Coverage
Bernstein: Initial rating for Affirm Holdings Affirm(AFRM.US) ) stock at "outperform", with a price target of $100.
Baird: CoreWeave ( CoreWeave(CRWV.US) ) initial rating at "outperform", with a price target of $100.
Canaccord Genuity: Initial rating for Nektar Therapeutics ( Nektar Therapeutics(NKTR.US) ) at "Buy", with a target price of $153.
reduction
Needham: Maintaining a "buy" rating on Applied Optoelectronics ( Applied Optoelectronics, Inc.(AAOI.US) ), while lowering the price target from $260 to $220.
B. Riley Securities: Maintaining a "neutral" rating on Amkor Technology ( Amkor Technology, Inc.(AMKR.US) ), while lowering the price target from $90 to $75.
TD Securities: Maintaining a "buy" rating on Danaher ( Danaher Corporation(DHR.US) ) stock, while lowering the price target from $240 to $236.
Editor's Note: This content was created by Saham's AI-powered SaaS tool and reviewed by our editorial team.
Risk Warning: Investing involves risk. Securities may rise, fall, or become worthless. Investing does not guarantee profits and may result in losses. Past performance is not necessarily indicative of future results. Before making any investment decision, investors should assess their financial situation, investment objectives, experience, risk tolerance, and understand the nature of the investment products and their associated risks. For more details on the nature and risks of each investment product, please read the relevant offering documents carefully. If you have any questions, it is advisable to seek independent professional advice.